CORRELATION BETWEEN GLYCAEMIC CONDITIONS WITH SIRT-1 GENE EXPRESSION LEVELS IN THE PROGRESSION OF DIABETIC RETINOPATHY

Article Sidebar

  PDF
Published Sep 30, 2025
DOI: https://doi.org/10.35479/ijretina.2025.vol008.iss002.317

Main Article Content

Mahaboob Vali Shaik
Department of Research, Nimra Institute of Medical Sciences, Vijayawada, AP, India
Skandha Harshita S
Assistant Professor, Department of Ophthalmology, Alluri Sitarama Raju Academy of Medical Sciences (ASRAMS), Eluru, West Godavari District-534005, AP.
Munni Shaik
Department of Research, Nimra Institute of Medical Sciences, Vijayawada, AP
John basha shaik
Department of Biochemistry, MNR Medical College & MNR University,Sangareddy, Telangana
Nissi Molli
Student, International National Indian School, Al Jubail, Saudi Arabia.
Swarna deepak Kuragayala
Department of Critical Care Medicine, Apollo Health City, Jubilee Hills, Hyderabad, Telangana
Jayaram G
Department of Physiology, Nimra Institute of Medical Sciences, Vijayawada, AP, India.
Vijaya Shekar Kola
Department of Ophthalmology, Nimra Institute of Medical Sciences, Vijayawada, AP, India.

Abstract

Background: Diabetic retinopathy (DR), a microvascular disorder, is commonly linked to diabetes. Diabetes mellitus' complex, progressive, and asymptomatic neurovascular effects make DR the leading cause of blindness and visual impairment in people of working age. Retinal neovascularisation determines whether DR is proliferative, non-proliferative, or diabetic macular oedema.


Aim: To evaluate the levels of SIRT-gene mRNA expression and how they relate to glycaemic status in patients with diabetic retinopathy.


Methods: The 60 cases in this study included 30 patients with diabetic retinopathy, 30 diabetic cases without retinopathy, and 30 non-diabetic controls. SIRT1 mRNA expression and basic laboratory measures were recorded.


Results: It was demonstrated that DR patients have down-regulated SIRT1 mRNA expression. The results of the study suggest that DR results from an imbalance between SIRT1 and IL-17 expression levels, with SIRT1 perhaps offering protection by preventing the production of IL-17. The DR cases had significantly lower levels of SIRT1 gene mRNA expression than the controls. The association between SIRT1 mRNA expression and four putative functional SNPs (rs12778366, rs3758391, rs2273773, and rs4746720) was examined. The findings showed that the allelic genes of rs3758391 showed substantial changes in SIRT1 mRNA expression in the healthy subjects (p<0.01). Compared to the controls (0.91±0.75 fold), SIRT1 mRNA expression levels were lower in the RD (0.61 ± 0.29 fold). SIRT1 gene expression decreases when HbA1c rises, indicating a negative connection between SIRT1 expression and HbA1c. This suggests that SIRT1 plays a protective function in preventing diabetic retinopathy (r = -0.245, p = 0.004). When comparing the Diabetes with Retinopathy Group to the Diabetes without Retinopathy Group1, SIRT1 Gene Expression was considerably lower, but IL17 was significantly greater (0.62±0.30 vs. 0.60±0.27, p=0.012).


Conclusion: In conclusion, the present data provide credence to the idea that the rs3758391 SNP affects mRNA expression in healthy people and that the SIRT1 gene guards against DR. In connection with the pathophysiology of DR, they also clarified the processes controlling the genetic regulation of the SIRT1 gene.

Keywords

Diabetic Retinopathy, SIRT-1 gene, neovascularization, microvascular disease

Article Details

How to Cite
SHAIK, Mahaboob Vali et al. CORRELATION BETWEEN GLYCAEMIC CONDITIONS WITH SIRT-1 GENE EXPRESSION LEVELS IN THE PROGRESSION OF DIABETIC RETINOPATHY. International Journal of Retina, [S.l.], v. 8, n. 2, sep. 2025. ISSN 2614-8536. Available at: <https://ijretina.com/index.php/ijretina/article/view/317>. Date accessed: 28 oct. 2025. doi: https://doi.org/10.35479/ijretina.2025.vol008.iss002.317.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 8 No 2 (2025): International Journal of Retina (IJRetina) - INAVRS
Section
Research Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

References

1. Mimura T, Kaji Y, Noma H, Funatsu H, Okamoto S. The role of SIRT1 in ocular aging. Exp Eye Res 2013;116:17–26.
2. Kowluru RA, Santos JM, Zhong Q. Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy. Invest Ophthalmol Vis Sci 2014;55:5653–5660.
3. Wang GL, Fu YC, Xu WC, Feng YQ, Fang SR, Zhou XH. Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1–FOXO1 signaling pathway. Biochemical and biophysical research communications. 2009 Mar 13;380(3):644-9.
4. Al Sabaani N. Kaempferol protects against hydrogen peroxide-induced retinal pigment epithelium cell inflammation and apoptosis by activation of SIRT1 and inhibition of PARP1. Journal of Ocular Pharmacology and Therapeutics. 2020 Sep 1;36(7):563-77.
5. Mishra M, Duraisamy AJ, Kowluru RA. Sirt1: a guardian of the development of diabetic retinopathy. Diabetes. 2018 Apr 1;67(4):745-54.
6. Pavlová S, Karolina K, Dušan V, Luboš R, Harrath AH, Alwasel SH, Sirotkin AV. The involvement of SIRT1 and transcription factor NF-κB (p50/p65) in regulation of porcine ovarian cell function. Animal Reproduction Science 2013; 140(3): 180-188.
7. Mishra M, Flaga J, Kowluru RA. Molecular mechanism of transcriptional regulation of matrix metalloproteinase‐9 in diabetic retinopathy. Journal of cellular physiology. 2016;231(8):1709-18.
8. Calabrese V, Scuto M, Salinaro AT, Dionisio G, Modafferi S, Ontario ML, Greco V, Sciuto S, Schmitt CP, Calabrese EJ, Peters V. Hydrogen sulfide and carnosine: modulation of oxidative stress and inflammation in kidney and brain axis. Antioxidants. 2020;9(12):1303.
9. Shimoyama Y, Mitsuda Y, Tsuruta Y, Suzuki K, Hamajima N, Niwa T: SIRTUIN 1 Gene Polymorphisms are Associated With Cholesterol Metabolism and Coronary Artery Calcification in Japanese Hemodialysis Patients. J Ren Nutr, 2012; 22: 114-119
10. Zillikens MC, van Meurs JB, Rivadeneira F, Amin N, Hofman A, Oostra BA, Sijbrands EJ, Witteman JC, Pols HA, van Duijn CM: SIRT1 genetic variation is related to BMI and risk of obesity. Diabetes, 2009; 58: 2828-2834
11. Shimoyama Y, Suzuki K, Hamajima N, Niwa T: Sirtuin 1 gene polymorphisms are associated with body fat and blood pressure in Japanese. Transl Res, 2011; 157: 339-347.
12. Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes, metabolic syndrome and obesity: targets and therapy. 2014 Dec 4:587-91
13. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda BI. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice. 2018 Apr 1;138:271-81.
14. Rodríguez ML, Pérez S, Mena-Mollá S, Desco MC, Ortega ÁL. Oxidative stress and microvascular alterations in diabetic retinopathy: future therapies. Oxidative Medicine and Cellular Longevity; 2019(1):4940825.
15. Niu J, Cao Y, Ji Y. Resveratrol, a SIRT1 activator, ameliorates MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia. Frontiers in psychiatry. 2020 Jul 24;11:716.
16. Ward LD, Kellis M. Interpreting noncoding genetic variation in complex traits and human disease. Nature biotechnology. 2012 Nov;30(11):1095-106.
17. Naqvi A, Hoffman TA, DeRicco J, Kumar A, Kim C-S, Jung S-B, Yamamori T, Kim Y-R, Mehdi F, Kumar S: A single-nucleotide variation in a p53-binding site affects nutrient-sensitive human SIRT1 expression. Hum Mol Genet, 2010; 19: 4123-4133
18. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell, 2001; 107: 137-148
19. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Sena- wong T, De Oliveira RM, Leid M, McBurney MW, Guar- ente L: Sirt1 promotes fat mobilization in white adipo- cytes by repressing PPAR-γ. Nature, 2004; 429: 771-776
20. Tu Y, Song E, Wang Z, Ji N, Zhu L, Wang K, Sun H, Zhang Y, Zhu Q, Liu X, Zhu M. Melatonin attenuates oxidative stress and inflammation of Müller cells in diabetic retinopathy via activating the Sirt1 pathway. Biomedicine & Pharmacotherapy. 2021 May 1;137:111274.
21. Liu, S., Lin, Y. and Liu, X. (2016): Protective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expression, Exp. Ther. Med. 11 (1) 257–262.
22. Song YS, Lee SK, Jang YJ, Park HS, Kim JH, Lee YJ, Heo YS. Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes. Diabetes research and clinical practice. 2013 Sep 1;101(3):341-8.
23. Al-Khaldi A, Sultan S. The expression of sirtuins, superoxide dismutase, and lipid peroxidation status in peripheral blood from patients with diabetes and hypothyroidism. BMC Endocrine Disorders. 2019 Dec;19:1-8.
24. Kitada, M., Koya, D. (2013). SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential Diabetes Metab J; 37:315-325.
25. Maloney SC, Antecka E, Granner T, Fernandes B, Lim LA, Orellana ME, Burnier MN. Expression of SIRT1 in choroidal neovascular membranes. Retina. 2013 Apr 1;33(4):862-6.
26. Qiu AW, Huang DR, Li B, Fang Y, Zhang WW, Liu QH. IL-17A injury to retinal ganglion cells is mediated by retinal Müller cells in diabetic retinopathy. Cell death & disease. 2021 Nov 8;12(11):1057.
27. Chang N, Li J, Lin S, Zhang J, Zeng W, Ma G, Wang Y. Emerging roles of SIRT1 activator, SRT2104, in disease treatment. Scientific Reports. 2024 Mar 6;14(1):5521.
28. Zhang, H., Wang, J., Ying, G.S., Shen, L., and Zhang, Z. (2014): Diabetic retinopathy and renal function in Chinese type 2 diabetic patients. Int Urol Nephrol; 46:1375-81.
29. Rutledge JC, Ng KF, Aung HH, Wilson DW. Role of triglyceride-rich lipoproteins in diabetic nephropathy. Nature Reviews Nephrology. 2010 Jun;6(6):361-70.
30. Mohan VA, Nithyanandam S, Idiculla J. Microalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy. Indian journal of ophthalmology. 2011 May 1;59(3):207-10.
31. Sobngwi E, Mbanya JC, Moukouri EN, Ngu KB. Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes research and clinical practice. 1999 Jun 1;44(3):191-6.